BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20406936)

  • 41. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up.
    Holmberg L; Sandin F; Bray F; Richards M; Spicer J; Lambe M; Klint A; Peake M; Strand TE; Linklater K; Robinson D; Møller H
    Thorax; 2010 May; 65(5):436-41. PubMed ID: 20435867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer survival in Qidong, China, 1992-2000.
    Chen JG; Zhu J; Zhang YH; Lu JH
    IARC Sci Publ; 2011; (162):43-53. PubMed ID: 21675405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer survival as a function of age at diagnosis: a study of the Surveillance, Epidemiology and End Results database.
    Bassily MN; Wilson R; Pompei F; Burmistrov D
    Cancer Epidemiol; 2010 Dec; 34(6):667-81. PubMed ID: 20466612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Choosing the relative survival method for cancer survival estimation.
    Hakulinen T; Seppä K; Lambert PC
    Eur J Cancer; 2011 Sep; 47(14):2202-10. PubMed ID: 21549589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer survival in Tianjin, China, 1991-1999.
    Xishan H; Chen K; Min H; Shufen D; Jifang W
    IARC Sci Publ; 2011; (162):69-84. PubMed ID: 21675407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.
    Berrino F; De Angelis R; Sant M; Rosso S; Bielska-Lasota M; Coebergh JW; Santaquilani M;
    Lancet Oncol; 2007 Sep; 8(9):773-83. PubMed ID: 17714991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer survival in Hong Kong SAR, China, 1996-2001.
    Law SC; Mang OW
    IARC Sci Publ; 2011; (162):33-41. PubMed ID: 21675404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study.
    Matsuda T; Ajiki W; Marugame T; Ioka A; Tsukuma H; Sobue T;
    Jpn J Clin Oncol; 2011 Jan; 41(1):40-51. PubMed ID: 20819833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent increase in cancer survival according to age: higher survival in all age groups, but widening age gradient.
    Brenner H; Arndt V
    Cancer Causes Control; 2004 Nov; 15(9):903-10. PubMed ID: 15577292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantifying differences in breast cancer survival between England and Norway.
    Lambert PC; Holmberg L; Sandin F; Bray F; Linklater KM; Purushotham A; Robinson D; Møller H
    Cancer Epidemiol; 2011 Dec; 35(6):526-33. PubMed ID: 21606014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United States.
    Rosso S; Gondos A; Zanetti R; Bray F; Zakelj M; Zagar T; Smailyte G; Ponti A; Brewster DH; Voogd AC; Crocetti E; Brenner H;
    Eur J Cancer; 2010 Dec; 46(18):3351-7. PubMed ID: 20943375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survival in patients with uveal melanoma in Europe.
    Virgili G; Gatta G; Ciccolallo L; Capocaccia R; Biggeri A; Crocetti E; Lutz JM; Paci E;
    Arch Ophthalmol; 2008 Oct; 126(10):1413-8. PubMed ID: 18852420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study.
    Andersson TM; Lambert PC; Derolf AR; Kristinsson SY; Eloranta S; Landgren O; Björkholm M; Dickman PW
    Br J Haematol; 2010 Mar; 148(6):918-24. PubMed ID: 19995394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A wide difference in cancer survival between middle aged and elderly patients in Europe.
    Quaglia A; Capocaccia R; Micheli A; Carrani E; Vercelli M
    Int J Cancer; 2007 May; 120(10):2196-201. PubMed ID: 17285582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival from rare cancer in adults: a population-based study.
    Gatta G; Ciccolallo L; Kunkler I; Capocaccia R; Berrino F; Coleman MP; De Angelis R; Faivre J; Lutz JM; Martinez C; Möller T; Sankila R;
    Lancet Oncol; 2006 Feb; 7(2):132-40. PubMed ID: 16455477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conditional survival among cancer patients in the United States.
    Merrill RM; Hunter BD
    Oncologist; 2010; 15(8):873-82. PubMed ID: 20647391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group.
    Vercelli M; Capocaccia R; Quaglia A; Casella C; Puppo A; Coebergh JW
    Crit Rev Oncol Hematol; 2000 Sep; 35(3):161-79. PubMed ID: 10960799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer survival increases in Europe, but international differences remain wide.
    Sant M; Capocaccia R; Coleman MP; Berrino F; Gatta G; Micheli A; Verdecchia A; Faivre J; Hakulinen T; Coebergh JW; Martinez-Garcia C; Forman D; Zappone A;
    Eur J Cancer; 2001 Sep; 37(13):1659-67. PubMed ID: 11527693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study.
    Brenner H; Bouvier AM; Foschi R; Hackl M; Larsen IK; Lemmens V; Mangone L; Francisci S;
    Int J Cancer; 2012 Oct; 131(7):1649-58. PubMed ID: 21607946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An update on cancer survival.
    Ellison LF; Wilkins K
    Health Rep; 2010 Sep; 21(3):55-60. PubMed ID: 20973434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.